Citadel Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.9M | Sell |
|
|||||
|
2025
Q2 | $19M | Sell |
|
|||||
|
2025
Q1 | $64.3M | Sell |
|
|||||
|
2024
Q4 | $73.9M | Buy |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.97M | Sell |
|
|||||
|
2023
Q4 | $13.7M | Buy |
|
|||||
|
2023
Q3 | $3.34M | Sell |
|
|||||
|
2023
Q2 | $20.1M | Sell |
|
|||||
|
2023
Q1 | $38.9M | Buy |
|
|||||
|
2022
Q4 | $20.2M | Buy |
|
|||||
|
2022
Q3 | $13.5M | Buy |
|
|||||
|
2022
Q2 | $10.9M | Sell |
|
|||||
|
2022
Q1 | $61.7M | Buy |
|
|||||
|
2021
Q4 | $8.44M | Buy |
|
|||||
|
2021
Q3 | $4.05M | Sell |
|
|||||
|
2021
Q2 | $20.1M | Buy |
|
|||||
|
2021
Q1 | $6M | Sell |
|
|||||
|
2020
Q4 | $16.2M | Buy |
|
|||||
|
2020
Q3 | $2.84M | Sell |
|
|||||
|
2020
Q2 | $44.8M | Buy |
|